Patents by Inventor Raoul Carubelli

Raoul Carubelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHITOSAN-DERIVED COMPOSITIONS
    Publication number: 20240117075
    Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.
    Type: Application
    Filed: August 23, 2023
    Publication date: April 11, 2024
    Inventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
  • Chitosan-derived compositions
    Patent number: 11773188
    Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.
    Type: Grant
    Filed: August 9, 2021
    Date of Patent: October 3, 2023
    Assignee: Immunophotonics, Inc
    Inventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
  • CHITOSAN-DERIVED COMPOSITIONS
    Publication number: 20220017647
    Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.
    Type: Application
    Filed: August 9, 2021
    Publication date: January 20, 2022
    Inventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
  • Chitosan-derived compositions
    Patent number: 11111316
    Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.
    Type: Grant
    Filed: July 5, 2018
    Date of Patent: September 7, 2021
    Assignee: IMMUNOPHOTONICS, INC.
    Inventors: Tomas Hode, Robert Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
  • Chitosan-Derived Compositions
    Publication number: 20200339706
    Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.
    Type: Application
    Filed: July 5, 2018
    Publication date: October 29, 2020
    Inventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
  • Chitosan-Derived Compositions
    Publication number: 20190002594
    Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.
    Type: Application
    Filed: July 5, 2018
    Publication date: January 3, 2019
    Inventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
  • Chitosan-Derived Compositions
    Publication number: 20180312611
    Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.
    Type: Application
    Filed: July 5, 2018
    Publication date: November 1, 2018
    Inventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
  • CHITOSAN-DERIVED COMPOSITIONS
    Publication number: 20150018748
    Abstract: The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.
    Type: Application
    Filed: January 17, 2013
    Publication date: January 15, 2015
    Applicant: IMMUNOPHOTONICS, INC.
    Inventors: Tomas Hode, Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Luciano Alleruzzo, Peter Jenkins, Kristopher Waynant, Joseph Raker
  • Solutions and films of glycated chitosan
    Publication number: 20060189573
    Abstract: Preparations containing glycated chitosan in a physiologically compatible carrier are described. Viscoelastic preparations comprise 1.0-12.0 percent by weight of glycated chitosan in an aqueous solution while lower viscosity solutions possess 0.1-0.5 percent by weight glycated chitosan. The otherwise free amino groups of the chitosan polymer are preferably 30-90% glycated and possess an average molecular weight of between 100,000 and 2,000,000 Daltons, and, most preferably between 100,000 and 1,000,000 Daltons.
    Type: Application
    Filed: April 14, 2006
    Publication date: August 24, 2006
    Inventors: Robert Nordquist, Raoul Carubelli
  • Solutions and films of glycated chitosan
    Publication number: 20050130932
    Abstract: Preparations containing glycated chitosan in a physiologically compatible carrier are described. Viscoelastic preparations comprise 1.0-12.0 percent by weight of glycated chitosan in an aqueous solution while lower viscosity solutions possess 0.1-0.5 percent by weight glycated chitosan. The otherwise free amino groups of the chitosan polymer are preferably 30-90% glycated and possess an average molecular weight of between 100,000 and 2,000,000 Daltons, and, most preferably between 100,000 and 1,000,000 Daltons.
    Type: Application
    Filed: June 28, 2004
    Publication date: June 16, 2005
    Inventors: Robert Norquist, Raoul Carubelli
  • Combined physical and immunotherapy for cancer
    Publication number: 20050106153
    Abstract: The present invention combines physical and immunologic therapies for the treatment of neoplasms by conditioning a targeted neoplasm with an immunoadjuvant (also called immuno-modulator or immunopotentiator) and then physically destroying the conditioned neoplasm. A number of physical therapies can be used to achieve the physical destruction of the conditioned tumor mass.
    Type: Application
    Filed: October 15, 2004
    Publication date: May 19, 2005
    Inventors: Robert Nordouist, Raoul Carubelli, Wei Chen
  • Solutions and films of glycated chitosan
    Patent number: 6756363
    Abstract: Preparations containing glycated chitosan in a physiologically compatible carrier are described. Viscoelastic preparations comprise 1.0-12.0 percent by weight of glycated chitosan in an aqueous solution while lower viscosity solutions possess 0.1-0.5 percent by weight glycated chitosan. The otherwise free amino groups of the chitosan polymer are preferably 30-90% glycated and possess an average molecular weight of between 100,000 and 2,000,000 Daltons, and, most preferably between 100,000 and 1,000,000 Daltons.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: June 29, 2004
    Assignee: Wound Healing of Oklahoma, Inc.
    Inventors: Robert E. Nordquist, Raoul Carubelli
  • Combined physical and immunotherapy for cancer
    Publication number: 20020136729
    Abstract: The present invention combines physical and immunologic therapies for the treatment of neoplasms by conditioning a targeted neoplasm with an immunoadjuvant (also called immunomodulator or immunopotentiator) and then physically destroying the conditioned neoplasm. A number of physical therapies can be used to achieve the physical destruction of the conditioned tumor mass.
    Type: Application
    Filed: November 5, 2001
    Publication date: September 26, 2002
    Applicant: Wound Healing of Oklahoma
    Inventors: Robert E. Nordquist, Raoul Carubelli, Wei R. Chen
  • Combined physical and immunotherapy for cancer
    Patent number: 6316007
    Abstract: The present invention combines physical and immunologic therapies for the treatment of neoplasms by conditioning a targeted neoplasm with an immunoadjuvant (also called immuno-modulator or immunopotentiator) and then physically destroying the conditioned neoplasm. A number of physical therapies can be used to achieve the physical destruction of the conditioned tumor mass.
    Type: Grant
    Filed: March 19, 1998
    Date of Patent: November 13, 2001
    Assignee: Wound Healing of Oklahoma
    Inventors: Robert E. Nordquist, Wei Chen, Raoul Carubelli
  • Laser/sensitizer assisted immunotherapy
    Patent number: 6290712
    Abstract: A method for treating a neoplasm, such as a malignant tumor, in humans and other animals, is disclosed. A chromophore and an immunoadjuvant are introduced into the neoplasm. The neoplasm is then lased at an irradiance sufficient to induce neoplastic cellular destruction and to stimulate the self-immunological defense system against neoplastic cellular multiplication.
    Type: Grant
    Filed: July 3, 1997
    Date of Patent: September 18, 2001
    Assignee: Wound Healing of Oklahoma
    Inventors: Robert E. Nordquist, Wei R. Chen, Raoul Carubelli
  • Laser/sensitizer assisted immunotherapy
    Patent number: 6149671
    Abstract: A method for treating a neoplasm, such as a malignant tumor, in humans and other animals, is disclosed. A chromophore and an immunoadjuvant are introduced into the neoplasm. The neoplasm is then lased at an irradiance sufficient to induce neoplastic cellular destruction and to stimulate the self-immunological defense system against neoplastic cellular multiplication.
    Type: Grant
    Filed: November 7, 1997
    Date of Patent: November 21, 2000
    Assignee: Wound Healings of Oklahoma
    Inventors: Robert E. Nordquist, Wei R. Chen, Raoul Carubelli
  • Chitosan-derived biomaterials
    Patent number: 5747475
    Abstract: Chitosan-derived biomaterials, and, more specifically, chitosan modified by the addition of a monosaccharide or oligosaccharide side chain to its free amino groups. The modified chitosan ("glycated chitosan") is preferably stabilized by reduction. In one particularly preferred embodiment, a galactose derivative of chitosan ("galacto-chitosan") is provided. The chitosan-derived biomaterials are useful in a myriad of biomedical applications, including as an immunoadjuvant in laser/sensitizer assisted immunotherapy.
    Type: Grant
    Filed: October 2, 1996
    Date of Patent: May 5, 1998
    Assignee: Wound Healing of Oklahoma
    Inventors: Robert E. Nordquist, Wei R. Chen, Raoul Carubelli, Robert Adams